Add Formweb to your mobile device
Ochsner Health COVID-19 SharePoint Site
"Safety On Site" Click here to enter an S.O.S.
Medications listed are available on OH EPIC Formulary, unless otherwise noted.
Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.
Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.
Search results for:
fentaNYL
fentaNYL
| Drug Name | Form | Strength | Infusion Center Available | Restricted | Non-formulary | Ambulatory Available | Interchange | REMS |
|---|---|---|---|---|---|---|---|---|
| FentaNYL | FILM, EXTENDED RELEASE, TRANSDERMAL | 12 mcg/hr; 25 mcg/hr; 75 mcg/hr | ||||||
| Duragesic-50 | FILM, EXTENDED RELEASE, TRANSDERMAL | 50 mcg/hr | ||||||
| Duragesic-100 | FILM, EXTENDED RELEASE, TRANSDERMAL | 100 mcg/hr | ||||||
| FentaNYL Citrate | SOLUTION, INJECTABLE | 3 mcg/mL | ||||||
| FentaNYL | SOLUTION, INJECTABLE | 10 mcg/mL - NS 1 mL (3 mL syringe) | ||||||
| FentaNYL Citrate | SOLUTION, INJECTABLE | 10 mcg/mL-0.9%; 50 mcg/mL | ||||||
| FentaNYL | SOLUTION, INJECTABLE | 2500 mcg/250 mL-D5% |
Last updated: Mar. 18, 2025
- Black Box Warning: Buccal Tablet: Serious adverse events, deaths; abuse potential
- Black Box Warning: Nasal Spray: Schedule II Controlled Substance: Abuse potential
- Black Box Warning: Sublingual Spray: Risk of respiratory depression, medication errors, abuse potential
- Black Box Warning: Transdermal: High concentration of Schedule II opioid agonist
- REMS: View FDA REMS Info
Restricted: